1Jaffe E S, Harris N L, Stein H, et al,eds. World Health Organization classification of tumours. Pathology and genetics of haemotopoietic and lymphoid tissue [ M ]. Lyon : IARC Press, 2001.
2Alizadeh A A, Eisen M B, Davis R E, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[ J ]. Nature, 2000, 403 : 503 - 511.
3Shipp M A, Ross K N, Tamayo D, et al. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning[J]. Nature Med ,2002, 8:64-74.
4Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B-cell lymphoma identifies a clinically favorable subgroup of diffuse large B-cell lymphoma related to Hodgkin lymphoma[ J ]. J Exp Med, 2003, 198 : 851 - 862.
5Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasma-blastic differentiation [J]. Curr Oncol Rep ,2005,7:357 - 363.
6Seegmiller A C, McKenna R W, Karandikar N J. Immunophenotypic differentiation between neoplastic plasma cells in non-Hodgkin lymphoma and plasma cell myeloma [ J ]. Mod Pathol ,2006, 19 ( Suppl 1 ) :246A.
7Bianco M K, Krochmal J D, Vasef M A. Transcription factor Pax-5 is consistently absent in plasma cell neoplasms [ J ]. Mod Pathol, 2006,19(Suppl 1): 19: 217A.
8Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL) : a clinicopathological study from the European MCL Network[J]. Br J Haematol, 2005, 131:29 -38.
9Fu K, Weisenburger D D, Greiner T C, et al. Cyclin Dl-negative mantle cell lymphoma. A clinicopathologic study based on gene expression profiling[J]. Blood, 2005, 106:4315 -4321.
10Haralambieva E, Baerma E J, van Imhoff G W, et al. Clinical,immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma[J]. Am J Surg Pathol,2005,29 : 1086 - 1094.
5Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large B- cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol, 2004, 15 ( 11 ) :1673-1679.
6Masgala A, Christopoulos C, Giannakou N, et al. Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol, 2007,86( 8 ) :615-618.
7Pruneri G, Graziadei G, Ermellino L, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica, 1998, 83(1 ) :87-89.
8Schichman SA, McClure R, Schaefer RF. et al. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol, 2004, 77 (3) :291-295.
9Tavora F, Gonzalez-Cuyar LF, Sun CC, et al. Extra-oral plasmablastic lymphoma : report of a case and review of literature. Hum Pathol, 2006 , 37(9) : 1233-1236.
10Seegmiller AC, Xu Y, McKenna RW, et al. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am J Clin Pathol, 2007, 127 (2) : 176-181.
